Correlation of pulmonary hypertension severity with metrics of comorbid sleep-disordered breathing

Sleep and Breathing

Volumn 15, Issue 4, 2011, Pages 633-639

  Prisco, Douglas L ^a   Sica, Anthony L ^a   Talwar, Arunabh ^a   Narasimhan, Mangala ^a   Omonuwa, Kennedy ^a   Hakimisefat, Babak ^a   Dedopoulos, Sophy ^a   Shakir, Nawid ^a   Greenberg, Harly ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Nocturnal hypoxemia; Pulmonary hypertension; Sleep apnea

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; EPWORTH SLEEPINESS SCALE; FEMALE; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HEART INDEX; HEART RIGHT ATRIUM PRESSURE; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SLEEP DISORDERED BREATHING; SLEEP TIME; SNORING; WORLD HEALTH ORGANIZATION; AGED; BLOOD; MIDDLE AGED; SLEEP APNEA SYNDROME; STATISTICS;

OXYGEN;

ADULT; AGED; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; OXYGEN; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC;

EID: 84859403186     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-010-0411-y     Document Type: Article

References (23)

1. McNicholas WT (2000) Impact of sleep in COPD. Chest 117(2):48-53 (suppl)
2. Minai OA, Ricaurte B, Kaw R, Hammel J, Mansour M, McCarthy K, Golish JA, Stoller JK (2009) Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol 104(9):1300-1306
3. Rafanan AL, Golish JA, Dinner DS, Hague LK, Arroliga AC (2001) Nocturnal hypoxemia is common in primary pulmonary hypertension. Chest 120:894-899 (Pubitemid 32885466)
4. Atwood CW Jr, McCroy D, Garcia JGN, Abman SH, Ahearn GS (2004) Pulmonary artery hypertension and sleep-disordered breathing. Chest 126(suppl 1):S72-S77
5. Minai OA, Pandya CM, Golish JA, Avecillas JF, McCarthy K, Marlow S, Arroliga AC (2007) Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension. Chest 131:109-117 (Pubitemid 46122981)
6. Ulrich S, Fischler M, Speich R, Bloch KE (2008) Sleep-related breathing disorders in patients with pulmonary hypertension. Chest 133:1375-1380 (Pubitemid 351892993)
7. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV (2007) Medical therapy for pulmonary arterial hypertension. Chest 131:1917-1928
8. American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111-117
9. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43:S40-S47
10. Iber C, Ancoli-Israel S, Chesson AL, Quan SF (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester, IL
11. Series ATS/ERS Task Force (2005) Standardisation of lung function testing. Numbers 2, 3, 4. Eur Respir J 26:319-338, 511-522; 720-735
12. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, Rapoport DM, Redline S, Resnick HE, Robbins JA, Shahar E, Unruh ML, Samet JM (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 6(8):e1000132
13. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. NEJM 328:1230-1235 (Pubitemid 23115702)
14. Podszus T, Greenberg H, Scharf SM (1994) Influence of sleep state and sleep disordered breathing on cardiovascular function. In: Saunders NA, Sullivan CE (eds) Sleep and breathing, 2nd edn. Marcel Dekker, New York, pp 257-299
15. Ward JP, McMurtry IF (2009) Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr Opin Pharmacol 9:287-296
16. Jeffery TK, Wanstall JC (2001) Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92(1):1-20 (Pubitemid 34032020)
17. McNicholas WT (2009) Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 51:392-399
18. Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, Godin-Ribuot D (2009) Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. Am Coll Cardiol 53(15):1309-1317
19. Gjroup PH, Sadauskiene L, Wessels K, Nyvad O, Strunge B, Pedersen EB (2007) Abnormally increased endothelin-1 in plasma during the night on obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 20:44-52 (Pubitemid 46014056)
20. Rhodes CJ, Davidson A, Gibbs JS, Wharton J, Wilkins MR (2009) Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther 121:69-88
21. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF (2006) Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343(2):591-596
22. Htoo AK, Greenberg H, Tongia S, Chen G, Henderson T, Wilson D, Liu SF (2006) Activation of nuclear factor kappa B in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10:43-50 (Pubitemid 44193436)
23. Rabinovitch M (2008) Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118:2372-2379